Guidelines for the management of chronic hepatitis C in patients infected after substance use
Journal | Volume 68 - 2005 |
Issue | Fasc.1 - Symposium |
Author(s) | G. Robaeys, F. Buntinx, E. Bottieau, S. Bourgeois, R. Brenard, I. Colle, J. De Bie, C. Matheï, J.P. Mulkay, P. Van Damme, M. Van Ranst, R. Verrando, P. Michielsen |
Full article |
VIEW FREE PDF |
(1) Department of Gastroenterology and Hepatology, Ziekenhuis Oost Limburg, Genk, Belgium ; (2) Department of General Practice, KULeuven, Leuven, Belgium ; (3) Institute of Tropical Medicine, Antwerp, Belgium ; (4) Department of Gastroenterology and Hepatology, ZNA Campus Stuivenberg, Antwerp, Belgium ; (5) Department of Gastroenterology and Hepatology, Hôpital St Joseph Gilly, Charleroi, Belgium ; (6) Department of Gastroenterology and Hepatology, Ghent University Hospital, Ghent, Belgium ; (7) Department of Psychiatry, Ziekenhuis Oost Limburg, Genk, Belgium ; (8) Department of General Practice, KULeuven, Leuven ; Free Clinic, Antwerp, Belgium ; (9) Department of Gastroenterology and Hepatology, CHU St Pierre, Brussels, Belgium ; (10) Centre for the Evaluation of Vaccination, Epidemiology and Community Medicine, University of Antwerp, Antwerp, Belgium ; (11) Laboratory of Clinical and Epidemiological Virology, Department of Microbiology and Immunology, University Hospital Leuven, Leuven, Belgium ; (12) Medisch Sociaal Opvang Centrum, Genk, Limburg, Belgium ; (13) Gastroenterology and Hepatology, University Hospital of Antwerp, Antwerp, Belgium. On behalf of the members of the Steering Committee of the Belgian Association for the Study of the Liver (BASL) : N. Bourgeois, R. Brenard, Ch. de Galocsy, J. Delwaide, J. Henrion, Y. Horsmans, P. Michielsen, H. Reynaert, G. Robaeys, D. Sprengers. |
These guidelines, from the Belgian Association for the Study of the Liver (BASL), contain evidence-based recommendations for the management of chronic hepatitis C (CHC) infection in substance users. |
© Acta Gastro-Enterologica Belgica. |